IP Library Granted Patent US 9,834,813
Granted Patent B2
US 9,834,813 · App. 13/825,223 · Granted Dec 5, 2017

Method for detecting mutant DNA

Inventors: Shoichi Matsukuma (Kanagawa, JP); Tomokazu Ishikawa (Hyogo, JP)
Assignees: Wako Pure Chemical Industries, Ltd.; Kanagawa Prefectural Hospital Organization
C12Q1/6827
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,834,813
App. No.
13/825,223
Granted
Dec 5, 2017
Kind
B2
Abstract

The present invention relates to a method for detecting of a mutant DNA using a probe, comprising: (1) contacting a sample containing a single-stranded DNA which has a substituted nucleotide, a deleted nucleotide region, or an inserted nucleotide region (mutant-type DNA), or/and a wild-type single-stranded DNA (wild-type DNA) corresponding thereto with the probe which hybridizes with both single-stranded DNA, to form a hybrid with the mutant-type DNA (mutant-type hybrid) or/and a hybrid with a wild-type DNA (wild-type hybrid), wherein at least one of the obtained mutant-type hybrid and wild-type hybrid has the stem structure; (2) separating the obtained mutant-type hybrid or/and wild-type hybrid by electrophoresis on the basis of presence or absence of the stem structure or difference in the stem structure; and (3) detecting the presence or absence of the mutant-type DNA in the sample.

Claims (41)

1. A method for detecting whether a wild-type nucleotide is substituted by a mutation nucleotide at a suspected mutated nucleotide site in a target DNA sequence, the method comprising:

(1) providing a probe having a structure comprising

3′ 1stSS 1 -X′ 1 -St P1 -X′ 2 -X′ 3 -X′ 4 -X′ 5 -2ndSS 1  5′;

or

3′ 1stSS 1 -X′ 1 -X′ 2 -X′ 3 -X′ 4 -St P1 -X′ 5 -2ndSS 1  5′;

wherein:

the length of the probe is 30 to 300 nucleotides;

1stSS 1 is a nucleotide sequence complementary to a portion of the target DNA sequence located on the 5′ side of the suspected mutation site and 2ndSS 1 is a nucleotide sequence complementary to a portion of the target DNA sequence located on the 3′ side of the suspected mutation site;

each of X′ 1 and X′ 5 independently represents a deoxyribonucleotide A, T, C, or G;

each of X′ 2 , X′ 3 , and X′ 4 independently represents a deoxyribonucleotide A, T, C, or G or a bond, wherein at most two of X′ 2 , X′ 3 , and X′ 4 are the bond, and wherein one of X′ 2 , X′ 3 , and X′ 4 is a deoxyribonucleotide A, T, C, or G which corresponds to the nucleotide of the suspected mutation nucleotide site and is complementary to the wild-type nucleotide when the suspected mutated nucleotide site contains the wild-type nucleotide; and

Stp 1 is a nucleotide sequence of 4 to 60 nucleotides that is capable of forming a double-stranded stem structure of 2 to 20 base pairs when the probe is hybridized with the target DNA sequence;

(2) contacting the probe with the sample containing the target DNA sequence in a solution under conditions capable of forming probe/target DNA sequence hybrids, wherein there is an electrophoretic mobility difference between the probe/target DNA sequence hybrids when the target DNA sequence has the wild-type nucleotide at the suspected mutated nucleotide site and the probe/target DNA sequence hybrids when the target DNA sequence has the mutation nucleotide at the suspected mutated nucleotide site;

(3) analyzing the probe/target DNA sequence hybrids formed in step (2) by an electrophoresis which is performed under conditions in which there is an electrophoretic mobility difference between the probe/target DNA sequence hybrids when the target DNA sequence has the wild-type nucleotide at the suspected mutated nucleotide site and the probe/target DNA sequence hybrids when the target DNA sequence has the mutation nucleotide at the suspected mutated nucleotide site, thereby obtaining an electrophoresis analysis result; and

(4) determining whether the wild-type nucleotide is substituted by the mutation nucleotide at the suspected mutated nucleotide site in the target DNA sequence in the sample by comparing the electrophoresis analysis result of step (3) with a first electrophoresis analysis result when the target DNA sequence has the wild-type nucleotide at the suspected mutation site or/and a second electrophoresis analysis result when the target DNA sequence has the mutation nucleotide at the suspected mutation site, wherein the first electrophoresis analysis result or/and the second electrophoresis analysis result is/are obtained by performing steps (1), (2) and (3).

2. The method according to claim 1 , further comprises subjecting a solution containing the probe and the target DNA sequence to thermal denaturation conditions and template elongation conditions.

3. The method according to claim 1 , wherein said contacting the probe with the sample comprises performing 1 to 4 cycles of: (i) heating the solution at 90° C. to 100° C. and (ii) heating the solution at 65° C. to 75° C.

4. The method according to claim 1 , wherein said contacting the probe with the sample comprises performing 1 to 4 cycles of: (i) heating the solution at 90° C. to 100° C., (ii) heating the solution at 30° C. to 55° C., and (iii) heating the solution at 65° C. to 75° C.

5. The method according to claim 1 , wherein the electrophoresis is microchip electrophoresis or capillary gel electrophoresis.

6. The method according to claim 1 , wherein X′ 1 is complementary to its corresponding nucleotide in the target DNA sequence and X′ 5 is complementary to its corresponding nucleotide in the target DNA sequence.

7. The method according to claim 1 , wherein St P1 is a nucleotide sequence further capable of forming a loop structure when the probe is hybridized with the target DNA sequence.

8. The method according to claim 1 , wherein the DNA target sequence in the probe/target DNA sequence hybrids forms a loop structure and/or a stem structure.

9. A method for detecting whether a wild-type nucleotide is substituted by a mutation nucleotide at a suspected mutated nucleotide site in a target DNA sequence in a sample, the method comprising:

(1) providing a probe having a structure comprising

3′ 1stSS 331 -X′ 331 -IM′ 331 -Stp 331 -X′ 332 -2ndSS 331  5′,

or

3′ 1stSS 331 -X′ 331 -Stp 331 -IM′ 331 -X′ 332 -2ndSS 331  5′

wherein:

the length of the probe is 30 to 300 nucleotides;

1stSS 1 is a nucleotide sequence complementary to a portion of the target DNA sequence located on the 5′ side of the suspected mutation site and 2ndSS 1 is a nucleotide sequence complementary to a portion of the target DNA sequence located on the 3′ side of the suspected mutation site;

each of X′ 1 and X′ 5 independently represents a deoxyribonucleotide A, T, C, or G;

each of X′ 2 , X′ 3 , and X′ 4 independently represents a deoxyribonucleotide A, T, C, or G or a bond, wherein at most two of X′ 2 , X′ 3 , and X′ 4 are the bond, and wherein one of X′ 2 , X′ 3 , and X′ 4 is a deoxyribonucleotide A, T, C, or G which corresponds to the nucleotide of the suspected mutation nucleotide site and is complementary to the mutation nucleotide when the suspected mutated nucleotide site contains the mutation nucleotide; and

Stp 1 is a nucleotide sequence of 4 to 60 nucleotides that is capable of forming a double-stranded stem structure of 2 to 20 base pairs when the probe is hybridized with the target DNA sequence;

(2) contacting the probe with the sample containing the target DNA sequence in a solution under conditions capable of forming probe/target DNA sequence hybrids, wherein there is an electrophoretic mobility difference between the probe/target DNA sequence hybrids when the target DNA sequence has the wild-type nucleotide at the suspected mutated nucleotide site and the probe/target DNA sequence hybrids when the target DNA sequence has the mutation nucleotide at the suspected mutated nucleotide site;

(3) analyzing the probe/target DNA sequence hybrids formed in step (2) by an electrophoresis which is performed under conditions in which there is an electrophoretic mobility difference between the probe/target DNA sequence hybrids when the target DNA sequence has the wild-type nucleotide at the suspected mutated nucleotide site and the probe/target DNA DNA sequence hybrids when the target DNA sequence has the mutation nucleotide at the suspected mutated nucleotide site, thereby obtaining an electrophoresis analysis result; and

(4) determining whether the wild-type nucleotide is substituted by the mutation nucleotide at the suspected mutated nucleotide site in the target DNA sequence in the sample by comparing the electrophoresis analysis result of step (3) with a first electrophoresis analysis result when the target DNA sequence has the wild-type nucleotide at the suspected mutation site or/and a second electrophoresis analysis result when the target DNA sequence has the mutation nucleotide at the suspected mutation site, wherein the first electrophoresis analysis result or/and the second electrophoresis analysis result is/are obtained by performing steps (1), (2) and (3).

10. The method according to claim 9 , further comprises subjecting a solution containing the probe and the target DNA sequence to thermal denaturation conditions and template elongation conditions.

11. The method according to claim 9 , wherein said contacting the probe with the sample comprises performing 1 to 4 cycles of: (i) heating the solution at 90° C. to 100° C. and (ii) heating the solution at 65° C. to 75° C.

12. The method according to claim 9 , wherein said contacting the probe with the sample comprises performing 1 to 4 cycles of: (i) heating the solution at 90° C. to 100° C., (ii) heating the solution at 30° C. to 55° C., and (iii) heating the solution at 65° C. to 75° C.

13. The method according to claim 9 , wherein the electrophoresis is microchip electrophoresis or capillary gel electrophoresis.

14. The method according to claim 9 , wherein X′ 1 is complementary to its corresponding nucleotide in the target DNA sequence and X′ 5 is complementary to its corresponding nucleotide in the target DNA sequence.

15. The method according to claim 9 , wherein St P1 is a nucleotide sequence further capable of forming a loop structure when the probe is hybridized with the target DNA sequence.

Assignments (2)
CHANGE OF NAME Recorded Dec 10, 2018
From: WAKO PURE CHEMICAL INDUSTRIES, LTD.
To: FUJIFILM WAKO PURE CHEMICAL CORPORATION
Reel/Frame 047725/0062 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 21, 2013
From: MATSUKUMA, SHOICHI; ISHIKAWA, TOMOKAZU
To: WAKO PURE CHEMICAL INDUSTRIES, LTD.; KANAGAWA PREFECTURAL HOSPITAL ORGANIZATION
Reel/Frame 030057/0311 →
Priority Claims (2)
JP 2010-212807 · Sep 22, 2010 · national
JP 2011-053901 · Mar 11, 2011 · national
Continuity (1)
Related Publication 20130217016A1 · Aug 22, 2013